Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 12/2011

01.12.2011 | Article

Revisited distribution of nonfermenting Gram-negative bacilli clinical isolates

verfasst von: H. Jacquier, E. Carbonnelle, S. Corvec, M. Illiaquer, A. Le Monnier, E. Bille, J. R. Zahar, J. L. Beretti, F. Jauréguy, V. Fihman, J. Tankovic, V. Cattoir

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Nonfermenting Gram-negative bacilli (NF-GNB) are ubiquitous environmental opportunistic bacteria frequently misidentified by conventional phenotypic methods. The aim of this study was to determine the distribution of NF-GNB species by 16 S rRNA gene sequencing (used as reference method) and to compare performances of biochemical tests and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). From nine French hospitals, 188 NF-GNB isolates (except P. aeruginosa and A. baumannii) were prospectively collected from 187 clinical samples between December 2008 and May 2009. By using the genotypic approach, 173 (92%) and 188 (100%) isolates were identified to the species and genus level, respectively. They covered 35 species and 20 genera, with a predominance of Stenotrophomonas maltophilia, Achromobacter xylosoxidans, and Pseudomonas putida group bacteria. Of the 173 species-level identified strains, concordant identification to the species-level was obtained for 75.1%, 83% and 88.9% of isolates with API 20 NE strip, the VITEK-2 (ID-GN card) system and MALDI-TOF-MS, respectively. By excluding S. maltophilia isolates accurately identified by the three methods, genus-level identification was much higher for MALDI-TOF-MS (92.9%), compared with API 20 NE and VITEK-2 (76.2% and 80.8%, respectively). In conclusion, MALDI-TOF-MS represents a rapid, inexpensive, and accurate tool for routine identification of NF-GNB in human clinical samples.
Literatur
1.
Zurück zum Zitat Enoch DA, Birkett CI, Ludlam HA (2007) Non-fermentative Gram-negative bacteria. Int J Antimicrob Agents 29(Suppl 3):S33–41PubMedCrossRef Enoch DA, Birkett CI, Ludlam HA (2007) Non-fermentative Gram-negative bacteria. Int J Antimicrob Agents 29(Suppl 3):S33–41PubMedCrossRef
2.
Zurück zum Zitat McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ (2000) Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 117:1661–1665PubMedCrossRef McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ (2000) Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 117:1661–1665PubMedCrossRef
3.
Zurück zum Zitat Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL (2003) Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting Gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 41:4312–4317PubMedCrossRef Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL (2003) Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting Gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 41:4312–4317PubMedCrossRef
4.
Zurück zum Zitat Ryan MP, Pembroke JT, Adley CC (2006) Ralstonia pickettii: a persistent gram-negative nosocomial infectious organism. J Hosp Infect 62:278–284PubMedCrossRef Ryan MP, Pembroke JT, Adley CC (2006) Ralstonia pickettii: a persistent gram-negative nosocomial infectious organism. J Hosp Infect 62:278–284PubMedCrossRef
5.
Zurück zum Zitat Bosshard PP, Zbinden R, Abels S, Boddinghaus B, Altwegg M, Bottger EC (2006) 16 S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 44:1359–1366PubMedCrossRef Bosshard PP, Zbinden R, Abels S, Boddinghaus B, Altwegg M, Bottger EC (2006) 16 S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 44:1359–1366PubMedCrossRef
6.
Zurück zum Zitat Wellinghausen N, Kothe J, Wirths B, Sigge A, Poppert S (2005) Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 43:4070–4075PubMedCrossRef Wellinghausen N, Kothe J, Wirths B, Sigge A, Poppert S (2005) Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis. J Clin Microbiol 43:4070–4075PubMedCrossRef
7.
Zurück zum Zitat Wallet F, Loiez C, Renaux E, Lemaitre N, Courcol RJ (2005) Performances of VITEK 2 colorimetric cards for identification of Gram-positive and Gram-negative bacteria. J Clin Microbiol 43:4402–4406PubMedCrossRef Wallet F, Loiez C, Renaux E, Lemaitre N, Courcol RJ (2005) Performances of VITEK 2 colorimetric cards for identification of Gram-positive and Gram-negative bacteria. J Clin Microbiol 43:4402–4406PubMedCrossRef
8.
Zurück zum Zitat Zbinden A, Bottger EC, Bosshard PP, Zbinden R (2007) Evaluation of the colorimetric VITEK 2 card for identification of Gram-negative nonfermentative rods: comparison to 16 S rRNA gene sequencing. J Clin Microbiol 45:2270–2273PubMedCrossRef Zbinden A, Bottger EC, Bosshard PP, Zbinden R (2007) Evaluation of the colorimetric VITEK 2 card for identification of Gram-negative nonfermentative rods: comparison to 16 S rRNA gene sequencing. J Clin Microbiol 45:2270–2273PubMedCrossRef
9.
Zurück zum Zitat Ferroni A, Sermet-Gaudelus I, Abachin E, Quesne G, Lenoir G, Berche P, Gaillard JL (2002) Use of 16 S rRNA gene sequencing for identification of nonfermenting Gram-negative bacilli recovered from patients attending a single cystic fibrosis center. J Clin Microbiol 40:3793–3797PubMedCrossRef Ferroni A, Sermet-Gaudelus I, Abachin E, Quesne G, Lenoir G, Berche P, Gaillard JL (2002) Use of 16 S rRNA gene sequencing for identification of nonfermenting Gram-negative bacilli recovered from patients attending a single cystic fibrosis center. J Clin Microbiol 40:3793–3797PubMedCrossRef
10.
Zurück zum Zitat Cloud JL, Harmsen D, Iwen PC, Dunn JJ, Hall G, Lasala PR, Hoggan K, Wilson D, Woods GL, Mellmann A (2010) Comparison of traditional phenotypic identification methods with partial 5′ 16 S rRNA gene sequencing for species-level identification of nonfermenting Gram-negative bacilli. J Clin Microbiol 48:1442–1444PubMedCrossRef Cloud JL, Harmsen D, Iwen PC, Dunn JJ, Hall G, Lasala PR, Hoggan K, Wilson D, Woods GL, Mellmann A (2010) Comparison of traditional phenotypic identification methods with partial 5′ 16 S rRNA gene sequencing for species-level identification of nonfermenting Gram-negative bacilli. J Clin Microbiol 48:1442–1444PubMedCrossRef
11.
Zurück zum Zitat Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49:543–551PubMedCrossRef Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49:543–551PubMedCrossRef
12.
Zurück zum Zitat Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G (2010) Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 48(5):1549–1554PubMedCrossRef Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G (2010) Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 48(5):1549–1554PubMedCrossRef
13.
Zurück zum Zitat Nagy E, Maier T, Urban E, Terhes G, Kostrzewa M (2009) Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect 15:796–802PubMedCrossRef Nagy E, Maier T, Urban E, Terhes G, Kostrzewa M (2009) Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect 15:796–802PubMedCrossRef
14.
Zurück zum Zitat Carbonnelle E, Beretti JL, Cottyn S, Quesne G, Berche P, Nassif X, Ferroni A (2007) Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 45:2156–2161PubMedCrossRef Carbonnelle E, Beretti JL, Cottyn S, Quesne G, Berche P, Nassif X, Ferroni A (2007) Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 45:2156–2161PubMedCrossRef
15.
Zurück zum Zitat Pignone M, Greth KM, Cooper J, Emerson D, Tang J (2006) Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. J Clin Microbiol 44:1963–1970PubMedCrossRef Pignone M, Greth KM, Cooper J, Emerson D, Tang J (2006) Identification of mycobacteria by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. J Clin Microbiol 44:1963–1970PubMedCrossRef
16.
Zurück zum Zitat Degand N, Carbonnelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A (2008) Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 46:3361–3367PubMedCrossRef Degand N, Carbonnelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Segonds C, Berche P, Nassif X, Ferroni A (2008) Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 46:3361–3367PubMedCrossRef
17.
Zurück zum Zitat Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332PubMedCrossRef Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332PubMedCrossRef
18.
Zurück zum Zitat Lane D (1991) 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M (eds) Nucleic acid techniques in bacterial systematics. John Wiley & Sons, Ltd, Chichester, United Kingdom, pp 115–175 Lane D (1991) 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M (eds) Nucleic acid techniques in bacterial systematics. John Wiley & Sons, Ltd, Chichester, United Kingdom, pp 115–175
19.
Zurück zum Zitat Clarridge JE 3rd (2004) Impact of 16 S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 17:840–862PubMedCrossRef Clarridge JE 3rd (2004) Impact of 16 S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 17:840–862PubMedCrossRef
20.
Zurück zum Zitat Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J (2000) Bacteraemia caused by non-glucose-fermenting Gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis 19:320–323PubMedCrossRef Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J (2000) Bacteraemia caused by non-glucose-fermenting Gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis 19:320–323PubMedCrossRef
21.
Zurück zum Zitat Jugo J, Kennedy R, Crowe MJ, Lamrock G, McClurg RB, Rooney PJ, Morris TC, Johnston PG (2002) Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital. J Hosp Infect 50:48–55PubMedCrossRef Jugo J, Kennedy R, Crowe MJ, Lamrock G, McClurg RB, Rooney PJ, Morris TC, Johnston PG (2002) Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital. J Hosp Infect 50:48–55PubMedCrossRef
22.
Zurück zum Zitat Aumeran C, Paillard C, Robin F, Kanold J, Baud O, Bonnet R, Souweine B, Traore O (2007) Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J Hosp Infect 65:47–53PubMedCrossRef Aumeran C, Paillard C, Robin F, Kanold J, Baud O, Bonnet R, Souweine B, Traore O (2007) Pseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J Hosp Infect 65:47–53PubMedCrossRef
23.
Zurück zum Zitat Nseir S, Di Pompeo C, Brisson H, Dewavrin F, Tissier S, Diarra M, Boulo M, Durocher A (2006) Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit Care 10:R143PubMedCrossRef Nseir S, Di Pompeo C, Brisson H, Dewavrin F, Tissier S, Diarra M, Boulo M, Durocher A (2006) Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit Care 10:R143PubMedCrossRef
24.
Zurück zum Zitat Saiman L, Siegel J (2004) Infection control in cystic fibrosis. Clin Microbiol Rev 17:57–71PubMedCrossRef Saiman L, Siegel J (2004) Infection control in cystic fibrosis. Clin Microbiol Rev 17:57–71PubMedCrossRef
25.
Zurück zum Zitat Funke G, Funke-Kissling P (2004) Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods. J Clin Microbiol 42:4067–4071PubMedCrossRef Funke G, Funke-Kissling P (2004) Evaluation of the new VITEK 2 card for identification of clinically relevant gram-negative rods. J Clin Microbiol 42:4067–4071PubMedCrossRef
26.
Zurück zum Zitat Mellmann A, Cloud J, Maier T, Keckevoet U, Ramminger I, Iwen P, Dunn J, Hall G, Wilson D, Lasala P, Kostrzewa M, Harmsen D (2008) Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16 S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 46:1946–1954PubMedCrossRef Mellmann A, Cloud J, Maier T, Keckevoet U, Ramminger I, Iwen P, Dunn J, Hall G, Wilson D, Lasala P, Kostrzewa M, Harmsen D (2008) Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16 S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 46:1946–1954PubMedCrossRef
27.
Zurück zum Zitat Mellmann A, Bimet F, Bizet C, Borovskaya AD, Drake RR, Eigner U, Fahr AM, He Y, Ilina EN, Kostrzewa M, Maier T, Mancinelli L, Moussaoui W, Prevost G, Putignani L, Seachord CL, Tang YW, Harmsen D (2009) High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol 47:3732–3734PubMedCrossRef Mellmann A, Bimet F, Bizet C, Borovskaya AD, Drake RR, Eigner U, Fahr AM, He Y, Ilina EN, Kostrzewa M, Maier T, Mancinelli L, Moussaoui W, Prevost G, Putignani L, Seachord CL, Tang YW, Harmsen D (2009) High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol 47:3732–3734PubMedCrossRef
28.
Zurück zum Zitat Minan A, Bosch A, Lasch P, Stammler M, Serra DO, Degrossi J, Gatti B, Vay C, D’Aquino M, Yantorno O, Naumann D (2009) Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry. Analyst 134:1138–1148PubMedCrossRef Minan A, Bosch A, Lasch P, Stammler M, Serra DO, Degrossi J, Gatti B, Vay C, D’Aquino M, Yantorno O, Naumann D (2009) Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry. Analyst 134:1138–1148PubMedCrossRef
Metadaten
Titel
Revisited distribution of nonfermenting Gram-negative bacilli clinical isolates
verfasst von
H. Jacquier
E. Carbonnelle
S. Corvec
M. Illiaquer
A. Le Monnier
E. Bille
J. R. Zahar
J. L. Beretti
F. Jauréguy
V. Fihman
J. Tankovic
V. Cattoir
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 12/2011
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1263-5

Weitere Artikel der Ausgabe 12/2011

European Journal of Clinical Microbiology & Infectious Diseases 12/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.